The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas

Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers. For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thou...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miaolong Lu, Ya Wang, Xianquan Zhan
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2019-05-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	MAPK ERK p38 JNK signaling pathway pituitary tumor
Accés en línia:	https://www.frontiersin.org/article/10.3389/fendo.2019.00330/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!